COMPOSITION | |
---|---|
K-MET 500 mg Tablets | |
Each Uncoated Sustained Release Tablet Contains: | |
Metformin Hydrochloride IP | 500 mg |
K-MET 1000 mg Tablets | |
Each Uncoated Sustained Release Tablet Contains: | |
Metformin Hydrochloride IP | 1000 mg |
INDICATIONS | |
In non-obese type 2 diabetes mellitus not adequately controlled with sulphonylureas. Obese type 2 diabetes mellitus not controlled by weight reduction and dietary modification. | |
DOSAGE AND ADMINISTRATION | |
Oral: Adults: One tablet to be taken once dialy with breakfast. Maximum dose for Metformin:2 gram daily in divided doses. | |
HOW SUPPLIED | |
10 Tablets per strip. |